Progenics Pharmaceuticals, Inc. (PGNX) Shares Gap Down Following Weak Earnings

... company's stock worth $10,370,000 after buying an additional 526,905 shares during the last quarter. Finally, Ardsley Advisory Partners purchased a new stake in Progenics Pharmaceuticals during the third quarter worth $2,912,000. Institutional ...
http://ift.tt/2pUAwXk